Soo Mary Scott, Baker Jay A, Rosen Eric L
Department of Radiology, Breast Imaging Division, Duke University Medical Center, P.O. Box 3808, Durham, NC 27710, USA.
AJR Am J Roentgenol. 2003 Apr;180(4):941-8. doi: 10.2214/ajr.180.4.1800941.
The purpose of this study was to evaluate the ability of sonography to depict and guide biopsies of mammographically suspicious microcalcifications and to reveal the mammographic features and histologic outcomes of lesions amenable to sonographically guided biopsy.
. Suspicious clusters of microcalcifications without other mammographic abnormalities were evaluated on sonography before biopsy and divided into two groups: those with and those without microcalcifications seen on sonography. Sonographically detected lesions underwent sonographically guided biopsy; lesions not seen on sonography underwent mammographically guided biopsy. Imaging features and histologies were correlated, and the positive predictive value of sonography was determined.
Of 111 lesions (105 patients), 26 lesions (23%) were identified and underwent sonographically guided biopsy; 85 lesions (77%) were not identified sonographically. The diameters of microcalcification clusters in the sonographically identified group were significantly larger (p = 0.0005) and contained larger numbers of microcalcification particles (p = 0.038) compared with clusters not identified sonographically. Sonographically identified lesions were seen as masses (77%) or dilated ducts (23%) with echogenic foci. Sonographically identified lesions were more likely to be malignant than those not seen on sonography (69% vs 21%, respectively; p < 0.00002). Of 38 malignant lesions, those visible on sonography were more likely to be invasive than those not seen on sonography (72% vs 28%, respectively; p = 0.018). In malignant lesions undergoing core biopsy and surgical excision, the extent of disease was underestimated less with sonographically guided biopsy (7%, 1/15) than with stereotactic biopsy (33%, 5/15).
Suspicious microcalcifications are seen infrequently on sonography (23%) but, when detected, can be successfully biopsied with sonographic guidance and more frequently are malignant and represent invasive cancer than those seen on mammography alone.
本研究的目的是评估超声描绘和引导乳腺钼靶检查中可疑微钙化活检的能力,并揭示适合超声引导活检的病变的乳腺钼靶特征和组织学结果。
在活检前对无其他乳腺钼靶异常的可疑微钙化簇进行超声评估,并分为两组:超声可见微钙化的组和超声未见微钙化的组。超声检测到的病变进行超声引导活检;超声未见的病变进行乳腺钼靶引导活检。将影像特征与组织学进行关联,并确定超声的阳性预测值。
在111个病变(105例患者)中,26个病变(23%)被识别并接受了超声引导活检;85个病变(77%)超声未识别。与超声未识别的微钙化簇相比,超声识别组中微钙化簇的直径显著更大(p = 0.0005),且包含的微钙化颗粒数量更多(p = 0.038)。超声识别的病变表现为肿块(77%)或伴有强回声灶的扩张导管(23%)。超声识别的病变比超声未见的病变更可能为恶性(分别为69%和21%;p < 0.00002)。在38个恶性病变中,超声可见的病变比超声未见的病变更可能为浸润性(分别为72%和28%;p = 0.018)。在接受粗针活检和手术切除的恶性病变中,超声引导活检低估疾病范围的比例(7%,1/15)低于立体定向活检(33%,5/15)。
超声很少能看到可疑微钙化(23%),但一旦检测到,可在超声引导下成功进行活检,且比仅通过乳腺钼靶检查发现的微钙化更常为恶性且代表浸润性癌。